Australia’s CSL is plopping down $11.7 billion to acquire Vifor Pharma, the Swiss biotech best known for its iron products and kidney drugs. While the buyout comes as little surprise — rumors have…
Philips is looking to bolster its vascular franchise by absorbing Vesper Medical, maker of stents designed to open up blocked or narrowed veins in the legs.
The manufacturing facility’s closure and subsequent layoffs will take effect Jan. 30.
Pfizer said it expects its antiviral pill Paxlovid to provide protection against the omicron variant of the coronavirus, amid worldwide concern that existing medications and vaccines would not work…
The FDA has added to the woes already troubling Merck’s HIV portfolio by slapping 13 clinical holds on its broad-based program for the confounding disease.
Novartis has canceled an agreement with Mesoblast on a failed COVID-19 cell therapy just as the Australian biotech tries to get a new phase 3 trial off the ground in the hopes the FDA will give the…
Sanofi’s hemophilia drug, put on pause last year, could be closer to the FDA’s doorstep on new late-stage data that shows the treatment significantly reduced bleeds. But the adverse events that raised…
A report added on the Business Market Insights titled North America Small Molecule Drug Discovery Market 2019 by Company Regions Type and Application Forecast to 2027 covers several well known…
Scientific Reports – The effectiveness of commercial household…
Galera’s shares were pummeled in the wake of news that its radiotherapy complication drug flunked a phase 3 study, but now the biotech says the study results were in error, and the treatment did, in…
